Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDC vs MRNA✓SelectedUSD · MRNAWDC vs MRNA performance historyLatest closeAs of-12.02%11/20
Stock and ETF performance explorer

WDC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+782.2%
MRNA return
+786.4%
Excess return
-4.2%
Maximum drawdown
-65.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-12.0%-2.2%-9.8%-11.9%
7D-11.7%-12.7%+1.0%-11.1%
30D-31.0%-20.7%-10.3%-30.3%
3M-44.3%+46.3%-90.6%-45.2%
6M-43.2%+305.2%-348.4%-49.5%
YTD+51.7%+561.2%-509.5%+28.5%
1Y+86.5%+772.1%-685.5%+54.3%
3Y+633.1%+147.0%+486.2%+549.8%
5Y+519.7%-26.1%+545.7%+464.7%
All+782.2%+786.4%-4.2%+721.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling